Evidence map›Paper›PMID 24981452›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

IκB kinase activity drives fetal lung macrophage maturation along a non-M1/M2 paradigm.

Ashley N Stouch, Rinat Zaynagetdinov, Whitney J Barham, Amanda M Stinnett, James C Slaughter, Fiona E Yull, Hal M Hoffman, Timothy S Blackwell, Lawrence S Prince

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. AMPK Activation: Respiratory Panacea?American journal of respiratory cell and molecular biology · 2023
    Article
  5. Article
  6. Article
  7. Halogen exposure injury in the developing lung.Annals of the New York Academy of Sciences · 2020
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Ashley N StouchDepartment of Pediatrics, University of California, San Diego, La Jolla, CA 92093; Rady Children's Hospital, San Diego, CA 92123;Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN 37232;Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232;Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN 37232; andDepartment of Biostatistics, Vanderbilt University, Nashville, TN 37232.
Rinat ZaynagetdinovDepartment of Pediatrics, University of California, San Diego, La Jolla, CA 92093; Rady Children's Hospital, San Diego, CA 92123;Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN 37232;Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232;Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN 37232; andDepartment of Biostatistics, Vanderbilt University, Nashville, TN 37232.
Whitney J BarhamDepartment of Pediatrics, University of California, San Diego, La Jolla, CA 92093; Rady Children's Hospital, San Diego, CA 92123;Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN 37232;Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232;Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN 37232; andDepartment of Biostatistics, Vanderbilt University, Nashville, TN 37232.
Amanda M StinnettDepartment of Pediatrics, University of California, San Diego, La Jolla, CA 92093; Rady Children's Hospital, San Diego, CA 92123;Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN 37232;Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232;Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN 37232; andDepartment of Biostatistics, Vanderbilt University, Nashville, TN 37232.
James C SlaughterDepartment of Pediatrics, University of California, San Diego, La Jolla, CA 92093; Rady Children's Hospital, San Diego, CA 92123;Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN 37232;Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232;Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN 37232; andDepartment of Biostatistics, Vanderbilt University, Nashville, TN 37232.
Fiona E YullDepartment of Pediatrics, University of California, San Diego, La Jolla, CA 92093; Rady Children's Hospital, San Diego, CA 92123;Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN 37232;Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232;Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN 37232; andDepartment of Biostatistics, Vanderbilt University, Nashville, TN 37232.
Hal M HoffmanDepartment of Pediatrics, University of California, San Diego, La Jolla, CA 92093; Rady Children's Hospital, San Diego, CA 92123;Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN 37232;Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232;Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN 37232; andDepartment of Biostatistics, Vanderbilt University, Nashville, TN 37232.
Timothy S BlackwellDepartment of Pediatrics, University of California, San Diego, La Jolla, CA 92093; Rady Children's Hospital, San Diego, CA 92123;Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN 37232;Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232;Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN 37232; andDepartment of Biostatistics, Vanderbilt University, Nashville, TN 37232.
Lawrence S PrinceDepartment of Pediatrics, University of California, San Diego, La Jolla, CA 92093; Rady Children's Hospital, San Diego, CA 92123;Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN 37232;Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232;Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN 37232; andDepartment of Biostatistics, Vanderbilt University, Nashville, TN 37232 lprinceucsd@gmail.com.
University of California, San Diego · USRady Children's Hospital-San Diego · USVanderbilt University · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
TRANSGENIC MOUSE/ ES CELL SHARES RESOURCESP60DK020593 · NIDDK · VANDERBILT UNIVERSITY · PI MCGUINNESS, OWEN P · 1986 to 2011
$28.1M
Shop Module CoreP30EY008126 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Kevin L Schey · 1989 to 2026
$19.6M
THREE-TIERED PREVENTION MODEL TO BETTER SERVE ALL STUDENP30HD015052 · NICHD · VANDERBILT UNIVERSITY · PI DYKENS, ELISABETH MAY · 1985 to 2014
$18.6M
Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2001 to 2015
$14.9M
Immunobiology of Blood and Vascular Systems Training ProgramT32HL069765 · NHLBI · VANDERBILT UNIVERSITY · PI HAWIGER, JACK J · 2002 to 2016
$6.5M
FGF-10 Expression in a Fetal Mouse Lung Model of Bronchopulmonary DysplasiaR01HL086324 · NHLBI · VANDERBILT UNIVERSITY · PI PRINCE, LAWRENCE S · 2008 to 2017
$3.7M
Role of Fetal Lung Macrophages in Broncopulmonary DysplasiaR01HL097195 · NHLBI · VANDERBILT UNIVERSITY · PI BLACKWELL, TIMOTHY S., PRINCE, LAWRENCE S · 2009 to 2013
$2.6M
Transcriptional Control of Lung Macrophage DevelopmentR01HL126703 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HOFFMAN, HAROLD M, PRINCE, LAWRENCE S · 2015 to 2018
$1.6M
Imaging Activated Macrophages in the LungsR01HL116358 · NHLBI · VANDERBILT UNIVERSITY · PI BLACKWELL, TIMOTHY S., PRINCE, LAWRENCE S · 2012 to 2014
$1.1M
NCI NIH HHS P30 CA068485NCRR NIH HHS S10 RR027396NEI NIH HHS P30 EY008126NHLBI NIH HHS HL069765NHLBI NIH HHS HL086324NHLBI NIH HHS HL097195NHLBI NIH HHS HL116358NHLBI NIH HHS R01 HL086324NHLBI NIH HHS R01 HL097195NHLBI NIH HHS R01 HL116358NHLBI NIH HHS R01 HL126703NHLBI NIH HHS T32 HL069765NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P30 DK058404NIDDK NIH HHS U24 DK059637
6 · The paper itself

Abstract

In preterm infants, exposure to inflammation increases the risk of bronchopulmonary dysplasia, a chronic, developmental lung disease. Although macrophages are the key cells that initiate lung inflammation, less is known about lung macrophage phenotype and maturation. We hypothesized that fetal lung macrophages mature into distinct subpopulations during mouse development, and that activation could influence macrophage maturation. Expression of the fetal macrophage markers CD68, CD86, CD206, Ym1, fibrinogen-like protein 2, and indolamine-2, 3-dioxygenase was developmentally regulated, with each marker having different temporal patterns. Flow cytometry analysis showed macrophages within the fetal lung were less diverse than the distinctly separate subpopulations in newborn and adult lungs. Similar to adult alveolar macrophages, fetal lung macrophages responded to the TLR4 agonist LPS and the alternative activation cytokines IL-4 and IL-13. Using a macrophage-specific constitutively active IκB Kinase transgenic model (IKFM), we demonstrated that macrophage activation increased proinflammatory gene expression and reduced the response of fetal lung macrophages to IL-4 and IL-13. Activation also increased fetal lung macrophage proliferation. Fetal IKFM lungs contained increased percentages of more mature, CD11b(low)F4/80(high) cells that also expressed higher levels of the alternative activation markers CD204 and CD206. Development of fetal lung macrophages into mature alveolar macrophages may therefore include features of both proinflammatory and alternative activation paradigms.

Indexed as

AnimalsAnimals, NewbornBiomarkersCell DifferentiationEnzyme ActivationFemaleGene Expression Regulation, DevelopmentalGene Expression Regulation, EnzymologicHumansI-kappa B KinaseImmunophenotypingInflammationLung DiseasesMacrophage ActivationMacrophages, AlveolarMacrophages, PeritonealBiomarkersI-kappa B Kinase

Identifiers

PMID24981452
PMCPMC4108541
OpenAlexW2134047989

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.